TY - JOUR
T1 - Phacoemulsification in patients with Baerveldt tube shunts
AU - Erie, Jay C.
AU - Baratz, Keith H.
AU - Mahr, Michael A.
AU - Johnson, Douglas H.
N1 - Funding Information:
Supported in part by Research to Prevent Blindness, Inc., New York, New York, and the Mayo Foundation, Rochester, Minnesota, USA.
PY - 2006/9
Y1 - 2006/9
N2 - Purpose: To investigate the effects of phacoemulsification in glaucomatous eyes with functioning Baerveldt tube shunts. Setting: Department of Ophthalmology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA. Methods: This retrospective analysis followed 9 eyes of 8 patients with functioning Baerveldt tube shunts who had clear corneal phacoemulsification. Intraocular pressure (IOP), number of glaucoma medications, corneal thickness, visual acuity, and additional glaucoma surgery were measured. Results: The mean follow-up was 21 months ± 3 (SD) (range 17 to 25 months). The mean change in IOP and the number of glaucoma medications used did not significantly change at 1 month (P>.19), 1 year (P>.17), or the last follow-up (P>.17). At the last examination, 2 eyes had IOP increases of 2 to 4 mm Hg, 3 eyes had no change, and 4 eyes had decreases of 4 to 7 mm Hg. Intraocular pressure increased in 1 eye at 8 months and required a tube shunt revision. No eye developed corneal decompensation. Visual acuity improved in 8 eyes; the mean improvement was 4 ± 3 Snellen lines. Conclusion: In most cases, phacoemulsification in glaucomatous eyes with a functioning Baerveldt tube shunt improved vision and maintained control of IOP.
AB - Purpose: To investigate the effects of phacoemulsification in glaucomatous eyes with functioning Baerveldt tube shunts. Setting: Department of Ophthalmology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA. Methods: This retrospective analysis followed 9 eyes of 8 patients with functioning Baerveldt tube shunts who had clear corneal phacoemulsification. Intraocular pressure (IOP), number of glaucoma medications, corneal thickness, visual acuity, and additional glaucoma surgery were measured. Results: The mean follow-up was 21 months ± 3 (SD) (range 17 to 25 months). The mean change in IOP and the number of glaucoma medications used did not significantly change at 1 month (P>.19), 1 year (P>.17), or the last follow-up (P>.17). At the last examination, 2 eyes had IOP increases of 2 to 4 mm Hg, 3 eyes had no change, and 4 eyes had decreases of 4 to 7 mm Hg. Intraocular pressure increased in 1 eye at 8 months and required a tube shunt revision. No eye developed corneal decompensation. Visual acuity improved in 8 eyes; the mean improvement was 4 ± 3 Snellen lines. Conclusion: In most cases, phacoemulsification in glaucomatous eyes with a functioning Baerveldt tube shunt improved vision and maintained control of IOP.
UR - http://www.scopus.com/inward/record.url?scp=33747337028&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33747337028&partnerID=8YFLogxK
U2 - 10.1016/j.jcrs.2006.04.008
DO - 10.1016/j.jcrs.2006.04.008
M3 - Article
C2 - 16931260
AN - SCOPUS:33747337028
SN - 0886-3350
VL - 32
SP - 1489
EP - 1491
JO - Journal of Cataract and Refractive Surgery
JF - Journal of Cataract and Refractive Surgery
IS - 9
ER -